Sinclair IS, UK Dermatology Specialist, Taps Quintiles To Enter Mexican Market
This article was originally published in The Pink Sheet Daily
Sinclair IS Pharma has inked a 10-year collaboration and licensing agreement with U.S.-based Quintiles to commercialize the small UK specialty pharma’s portfolio of dermo-cosmetic products and medical devices in Mexico, building another bridge for the British company into emerging markets as it continues to expand outside of its core, depressed European home base.
You may also be interested in...
Trulicity’s broad CV label awarded by the US FDA should aid overall uptake of the GLP-1 class, cushioning the direct impact on Novo Nordisk’s rival, Ozempic, analysts said.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.
Deal news from Bayer, Nuvisan, Inamed, BioMotiv, Bristol-Myers Squibb, Collegium, Assertio, Merck & Co., KalVista, Atreca, Coda, Attenua, Aimmune, Xencor, EyePoint, Equinox, Allergan, Nestle, Zealand, Valeritas…